EPALRESTAT News
EPALRESTAT currently has 0 news articles, with 12 predicted indications.
This page combines the AI-predicted indications for EPALRESTAT with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (12):
- diabetic polyneuropathy (99.0%)
- diabetic neuropathy (99.0%)
- type 2 diabetes nephropathy (99.2%)
- Tay-Sachs disease (98.7%)
- mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies (98.6%)
- growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant (98.6%)
- Gaucher disease (98.5%)
- adult Krabbe disease (98.4%)
- cholesterol metabolism disease (98.4%)
- infantile neuronal ceroid lipofuscinosis (98.4%)
- autosomal ichthyosis syndrome with fatal disease course (98.3%)
- familial generalized lentiginosis (98.3%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.